Meridian Bioscience Inc (NASDAQ:VIVO)
| 21.71 Data as of May 22 |  -0.22 / -1.00%Today’s Change | 16.19 Today|||52-Week Range 23.05 | +7.21% Year-to-Date |
Latest VIVO News | Press Releases
No recent news for Meridian Bioscience Inc.
Today’s Trading
| Previous close | 21.93 |
| Today’s open | 21.92 |
| Day’s range | -- - -- |
| Volume | 176,508 |
| Average volume (3 months) | 172,628 |
| Market cap | $900.2M |
| Dividend yield | 3.50% |
Data as of 05/22/2013
Growth & Valuation
| Earnings growth (last year) | +23.08% |
| Earnings growth (this year) | +8.72% |
| Earnings growth (next 5 years) | +17.00% |
| Revenue growth (last year) | +8.65% |
| P/E ratio | 25.5 |
| Price/Sales | 4.54 |
| Price/Book | 6.28 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| QDELQuidel Corp | -0.71 | -3.13% |
| GHDXGenomic Health Inc | +0.14 | +0.38% |
| DNDNDendreon Corp | -0.01 | -0.25% |
| NEOGNeogen Corp | -1.04 | -1.88% |
Data as of 4:00pm ET, 05/22/2013
Financials
| Next reporting date | July 18, 2013 |
| EPS forecast (this quarter) | $0.22 |
| Annual revenue (last year) | $173.5M |
| Annual profit (last year) | $33.4M |
| Net profit margin | 19.23% |
Profile
Sector Health Technology |
Industry Biotechnology |
Executive Chairman William J. Motto |
CEO, Director & Head-Media Relations John A. Kraeutler |
Corporate headquarters Cincinnati, Ohio |
Forecasts
